Q3 2024 Earnings Estimate for Astrana Health, Inc. (NASDAQ:ASTH) Issued By William Blair

Astrana Health, Inc. (NASDAQ:ASTH) – Equities researchers at William Blair upped their Q3 2024 earnings per share estimates for shares of Astrana Health in a research note issued to investors on Tuesday, May 7th. William Blair analyst R. Daniels now expects that the company will post earnings of $0.43 per share for the quarter, up from their previous estimate of $0.41. The consensus estimate for Astrana Health’s current full-year earnings is $1.65 per share. William Blair also issued estimates for Astrana Health’s Q1 2025 earnings at $0.36 EPS, Q2 2025 earnings at $0.39 EPS and FY2025 earnings at $1.48 EPS.

Several other equities research analysts have also recently commented on the company. Truist Financial boosted their target price on Astrana Health from $41.00 to $44.00 and gave the company a “hold” rating in a research note on Friday, March 1st. Jefferies Financial Group started coverage on Astrana Health in a research note on Monday, February 26th. They set a “buy” rating and a $50.00 price objective on the stock. Finally, Stifel Nicolaus dropped their price objective on Astrana Health from $50.00 to $45.00 and set a “buy” rating on the stock in a research note on Wednesday.

Astrana Health Stock Performance

NASDAQ ASTH opened at $38.09 on Thursday. The company has a market cap of $2.13 billion, a PE ratio of 28.86, a price-to-earnings-growth ratio of 1.20 and a beta of 1.12. The company has a 50 day moving average price of $40.24. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.11 and a quick ratio of 2.11. Astrana Health has a 52 week low of $28.86 and a 52 week high of $45.71.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Tuesday, May 7th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). The firm had revenue of $404.36 million during the quarter, compared to the consensus estimate of $413.84 million. Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The company’s revenue was up 19.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.42 EPS.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.